Jump to main content
Jump to site search

Issue 7, 2020
Previous Article Next Article

Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer

Author affiliations

Abstract

Precise diagnosis and effective treatment are crucial to the prognosis of pancreatic ductal adenocarcinoma (PDAC). Magnetic iron oxide nanoparticles (IONPs) are superior magnetic resonance imaging (MRI) contrast agents, while antibodies are significant immunotherapy reagents. Herein, we firstly generated a novel nanocomposite combining triple single chain antibodies (scAbs) and IONPs for the detection and treatment of PDAC. Methods: Triple scAbs (scAbMUC4, scAbCEACAM6, scFvCD44v6, MCC triple scAbs) were conjugated to the surface of polyethylene glycol modified IONPs (IONPs-PEG), forming the IONPs-PEG-MCC triple scAbs nanocomposite. Characterization of the nanocomposite was performed, and its cytotoxicity, specificity, and apoptosis induction were evaluated. In vivo MRI study and anti-pancreatic cancer effect assessment were performed in tumor-bearing nude mice. Results: The size of the IONPs-PEG-MCC triple scAbs nanocomposite was about 23.6 nm. The nanocomposite was non-toxic to normal pancreatic ductal epithelial cells, and could specifically bind to and be internalized by MUC4/CEACAM6/CD44v6-expressing PDAC cells. With an r2 relaxivity of 104.2 mM−1 s−1, the IONPs-PEG-MCC triple scAbs nanocomposite could significantly shorten the MRI T2-weighted signal intensity both in vitro and in vivo. The IONPs-PEG-MCC triple scAbs nanocomposite also showed a favorable anti-pancreatic cancer effect. Conclusion: In the present study, the IONPs-PEG-MCC triple scAbs nanocomposite was firstly confirmed as a bi-functional nanocomposite in both MRI and treatment, providing its critical clinical transformation potential in PDAC detection and treatment.

Graphical abstract: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer

Back to tab navigation

Supplementary files

Article information


Submitted
11 Jun 2019
Accepted
11 Jan 2020
First published
13 Jan 2020

Nanoscale, 2020,12, 4473-4490
Article type
Paper

Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer

J. Zou, S. Chen, Y. Li, L. Zeng, G. Lian, J. Li, S. Chen, K. Huang and Y. Chen, Nanoscale, 2020, 12, 4473
DOI: 10.1039/C9NR04976B

Social activity

Search articles by author

Spotlight

Advertisements